MR Certification Programme · Nuin Wellness Pvt. Ltd.

The Complete
Wound Healing
Nutrition Training

Master the science, evidence, and sales skills behind Epithrive® — India's first targeted wound healing nutrition formula. Eight modules. One certification.

8
Modules
14+
Hours
40
Exam Questions
80%
Pass Mark
Scroll
0/8
Complete

Your Training Progress

Progress is saved in your browser automatically as you open each module. Complete all 8 modules to unlock the certification exam.

Eight Modules.
Every Dimension of Epithrive®.

From wound cell biology to field objection handling — structured in the sequence every MR must master before their first solo call.

Certification Track

Become an
Epithrive® Certified
Product Expert

Complete all 8 training modules, then sit the 40-question certification examination. Pass with 80% or higher to earn your official certification — the credential required for solo field deployment.

1
Complete all 8 training modules in sequence
2
Practise the 3-minute detailing drill and role-plays (Module 7)
3
Complete the 40-question exam in 60 minutes or less
4
Score 32/40 or above (80%) to pass
5
Print your certificate — authorised for solo field deployment
🏅
Nuin Wellness Pvt. Ltd. · ZenFitra Lifesciences
Epithrive® Certified
Product Expert
Your Name
has successfully completed the Epithrive® MR Training Programme
40-Question Examination · Pass Mark 80%

Key Facts at a Glance

The numbers and details every MR must know cold — before any doctor call.

Product Details

BrandEpithrive®
CompanyNuin Wellness Pvt. Ltd.
Format24g sachet · Orange flavour
Pack & Price₹3,995 / 10-sachet box
Dose1–2 sachets/day in 200ml water
DurationMin 4–6 weeks until closure
SugarNo added sugar — diabetic safe

Regulatory & Registration

CategoryNutraceutical (FSSAI)
FSSAI Lic. No.11524998000214
Valid Until15 February 2030
TM Reg. No.6248396
FSMP StatusApplication in progress — NOT yet approved
ManufacturerVital Nutraceuticals Pvt. Ltd.
Mfr StandardsISO 22000:2018 · cGMP · HACCP

Clinical Study — India

Study CodeCSR-ETH-2025-001
DesignProspective open-label comparative
n60 patients (30 per arm)
Primary Finding72.4% vs 52.1% wound area reduction at Week 8
p-valuep = 0.004 (highly significant)
Principal InvestigatorDr. B. Praful, MS Ortho
OrderingWhatsApp: +91 99708 43254